Combination of CpG and antibodies directed against CD19, CD20, CD22 or CD40 for the treatment or prevention of cancer.

摘要

An immunostimulatory nucleic acid that has a non-methylated CpG motif and an ability to regulate to higher levels the expression of an antigen, and an antibody specific for said antigen, in which the antigen is a CD19, CD20, CD22 or CD40 antigen, for Use in the treatment or prevention of cancer.